Nbryo launches Spring Trial Ambassador Program
Priority access and discounted IVF rates for AWA members
Imagine being able to identify your best genetics, genomically select the traits you’d like, multiply these many times over and then AFFORDABLY transfer these into recipient females. This is the Nbryo vision.
After more than 15 years of R&D, major grant funding and input from universities, companies and research institutions globally, Nbryo’s game-changing technology platform is poised to transform the entire value chain. Research to develop the Nbryo platform has been funded by MLA, the Bill & Melinda Gates Foundation and Nbryo Pty Ltd. Additionally, Nbryo has attracted significant equity investment to further its commercialisation capability.
The challenge to date has been that existing assisted breeding technologies are out-dated and difficult to scale. A typical well-run genetic improvement program today, can deliver at best, a 10% change in a trait or an index of traits in a 7-year period.
As the Nbryo platform rolls out, it will be possible for example, to select the top 10% of embryos with the traits that are desired (in the dish/lab), multiply these and discard the other 90%. For Wagyu breeders, this could mean initially selecting for male or female progeny, eliminating animals carrying the horned gene and eliminating any embryos carrying undesirable genetic conditions. The resulting embryos can then be scaled significantly.
With the ability to condense 7 years of genetic improvement into 7 days and technology being developed to enable semi-skilled operators to transfer embryos into exactly the right place and at the right time, this ambitious vision is on the cusp of being realised.
With the lab operational and live calves on the ground from our existing technology Nbryo is now ‘open for business’.
As part of its Platinum Partnership, Nbryo is offering AWA members discounted rates and priority access to its Spring Trial Ambassador Program* (TAP). To find out more, click the button below and/or learn more from the Nbryo Webinar being held for AWA members only from 7.30-8.15pm on Monday 5th August.
*Terms & Conditions apply